Lori A. Woods is CEO at Perspective Therapeutics, Inc. (ISR). They have made 11 open-market trades across 2 companies since 2008, most recently 2025-03-31.
CIK 0001393007
11 open-market purchases totalling $474K since 2008, never a sale. Across 11 scored buys the stock is up 108.0% at ninety days, and 102.2 points ahead of the S&P over the same stretch.
11 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 55% | 64% | 100% |
| Avg Move | +5.5% | +11.2% | +108.0% |
| Alpha | +5.6% | +10.5% | +102.2% |
| Scored | 11 | 11 | 11 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CATX | BUY | 2025-03-31 | 2025-04-01 | $2.13 | $100K | -4.4% | +21.1% | +68.6% |
| CATX | BUY | 2024-06-14 | 2024-06-18 | $10.90 | $50K | -6.7% | -1.0% | +9.2% |
| CATX | BUY | 2024-06-03 | 2024-06-04 | $1.46 | $50K | -21.9% | -21.8% | +3.5% |
| CATX | BUY | 2023-12-14 | 2023-12-18 | $0.27 | $50K | +54.6% | +67.7% | +271.0% |
| ISR | BUY | 2022-11-15 | 2022-11-17 | $0.34 | $34K | +1.8% | -28.2% | +1.0% |
| ISR | BUY | 2022-06-07 | 2022-06-09 | $0.30 | $23K | -6.2% | +2.9% | +16.5% |
| ISR | BUY | 2020-11-30 | 2020-12-02 | $0.38 | $26K | +5.4% | +37.6% | +259.0% |
| ISR | BUY | 2020-10-22 | 2020-10-28 | $0.52 | $25K | +1.2% | -11.5% | +403.6% |
| ISR | BUY | 2019-11-14 | 2019-11-19 | $0.40 | $60K | +61.9% | +49.3% | +145.2% |
| ISR | BUY | 2018-11-14 | 2018-11-15 | $0.40 | $52K | +5.0% | +1.3% | +5.0% |
| ISR | BUY | 2008-05-19 | 2008-05-21 | $0.90 | $5K | -30.4% | +5.4% | +5.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.